EPS Bio Technology Corp. (TPEX:4183)
Taiwan · Delayed Price · Currency is TWD 13.00
-0.05 (-0.38%)
May 29, 2026, 1:00 PM CST
EPS Bio Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -21.34 | -7.87 | 17.31 | 20.99 | 25.36 | 18.64 |
Depreciation & Amortization | 15.8 | 15.11 | 14.18 | 14.9 | 16.62 | 17.85 |
Other Amortization | 0.27 | 0.27 | 0.42 | 0.6 | 0.69 | 0.73 |
Loss (Gain) From Sale of Assets | 0 | 0 | - | 0.26 | - | - |
Provision & Write-off of Bad Debts | 3.37 | 2.6 | -1.89 | 0.16 | 2.61 | 1.2 |
Other Operating Activities | 3.41 | -0.99 | -15.52 | 5.45 | -10.33 | 7.63 |
Change in Accounts Receivable | 22.92 | -3.35 | -51.18 | -17.08 | 20.8 | -21.49 |
Change in Inventory | -7.46 | 7.17 | -8.39 | 10.86 | -4.89 | -35.46 |
Change in Accounts Payable | -36.25 | -7.85 | 5.84 | 16.42 | -23.15 | 24.82 |
Change in Unearned Revenue | -11.49 | -5.37 | 9.96 | 3.97 | -27.69 | 22.7 |
Change in Other Net Operating Assets | 2.78 | 0.87 | -3.07 | -1.35 | 4.98 | -4.54 |
Operating Cash Flow | -28.12 | 0.6 | -32.34 | 55.17 | 5 | 32.08 |
Operating Cash Flow Growth | - | - | - | 1003.86% | -84.42% | -59.85% |
Capital Expenditures | -17.38 | -22.36 | -13.9 | -9.48 | -14.95 | -11.75 |
Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - |
Sale (Purchase) of Intangibles | -1.61 | -1.61 | -0.51 | - | - | -0.39 |
Other Investing Activities | - | - | - | - | 0.04 | - |
Investing Cash Flow | -18.98 | -23.97 | -14.4 | -9.48 | -14.92 | -12.14 |
Short-Term Debt Issued | - | 50 | - | - | - | - |
Total Debt Issued | 90 | 50 | - | - | - | - |
Short-Term Debt Repaid | - | -10 | - | - | - | - |
Long-Term Debt Repaid | - | -6.06 | -5.68 | -5.59 | -5.93 | -5.46 |
Total Debt Repaid | -56.09 | -16.06 | -5.68 | -5.59 | -5.93 | -5.46 |
Net Debt Issued (Repaid) | 33.92 | 33.94 | -5.68 | -5.59 | -5.93 | -5.46 |
Common Dividends Paid | -15.95 | -15.95 | -19.04 | -23.32 | -16.66 | -28.56 |
Financing Cash Flow | 17.97 | 18 | -24.72 | -28.91 | -22.59 | -34.02 |
Foreign Exchange Rate Adjustments | -1.12 | -0.49 | 5.11 | -0.15 | 7.75 | -4.38 |
Net Cash Flow | -30.25 | -5.86 | -66.35 | 16.63 | -24.76 | -18.45 |
Free Cash Flow | -45.5 | -21.76 | -46.24 | 45.69 | -9.96 | 20.34 |
Free Cash Flow Growth | - | - | - | - | - | -72.30% |
Free Cash Flow Margin | -10.26% | -4.35% | -10.25% | 9.72% | -2.15% | 4.23% |
Free Cash Flow Per Share | -1.91 | -0.91 | -1.94 | 1.91 | -0.42 | 0.85 |
Cash Interest Paid | 2.06 | 1.9 | 2.05 | 2.14 | 2.13 | 2.18 |
Cash Income Tax Paid | 0.64 | 0.64 | 6.59 | 6.48 | 3.77 | 4.32 |
Levered Free Cash Flow | - | -24.01 | -60.98 | 39.95 | -22.31 | 15.26 |
Unlevered Free Cash Flow | - | -22.82 | -59.7 | 41.29 | -20.98 | 16.63 |
Change in Working Capital | -29.5 | -8.53 | -46.84 | 12.82 | -29.94 | -13.96 |